News Earnings Avantel Limited Reports Q3FY26 Results with Revenue Decline of 27.3% Year-on-YearAvantel Limited Reports Q3FY26 Results with Revenue Decline of 27.3% Year-on-Year
Avantel Limited reported Q3FY26 standalone revenue of ₹5,124.52 lakhs, declining 27.3% year-on-year from ₹7,043.83 lakhs. Net profit dropped significantly by 77.7% to ₹465.74 lakhs compared to ₹2,090.48 lakhs in Q3FY25. Nine-month revenue fell 20.6% to ₹15,820.57 lakhs while net profit declined 70.6% to ₹1,544.74 lakhs. The company operates in communications/signal processing and healthcare segments through subsidiary iMeds Global Private Limited.
*this image is generated using AI for illustrative purposes only.
Avantel Limited has announced its unaudited financial results for the third quarter ended December 31, 2025, revealing a challenging performance with significant declines in both revenue and profitability compared to the previous year. The Board of Directors approved these results during their meeting held on January 25, 2026.
Standalone Financial Performance
The company's standalone operations showed a marked deterioration in Q3FY26 performance. Revenue from operations declined substantially, while profitability was significantly impacted across all key metrics.
| Financial Metric | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations | ₹5,124.52 lakhs | ₹7,043.83 lakhs | -27.3% |
| Total Income | ₹5,165.84 lakhs | ₹7,093.24 lakhs | -27.2% |
| Net Profit | ₹465.74 lakhs | ₹2,090.48 lakhs | -77.7% |
| Basic EPS | ₹0.17 | ₹0.90 | -81.1% |
Nine-Month Performance Analysis
The nine-month period ending December 31, 2025, also reflected similar declining trends, with the company facing headwinds across its operational metrics.
| Parameter | 9M FY26 | 9M FY25 | Variance (%) |
|---|---|---|---|
| Revenue from Operations | ₹15,820.57 lakhs | ₹19,934.10 lakhs | -20.6% |
| Net Profit | ₹1,544.74 lakhs | ₹5,255.90 lakhs | -70.6% |
| Basic EPS | ₹0.57 | ₹2.27 | -74.9% |
Consolidated Results and Segment Performance
On a consolidated basis, which includes subsidiary iMeds Global Private Limited, the company reported Q3FY26 revenue of ₹5,171.58 lakhs compared to ₹7,068.08 lakhs in Q3FY25. Consolidated net profit for the quarter stood at ₹274.35 lakhs versus ₹2,008.07 lakhs in the previous year.
The company operates through two distinct business segments:
- Communications and Signal Processing Products: Manufacturing wireless front end, satellite communication, embedded systems, and related services
- Healthcare Services: Manufacturing disposable skin staplers, removers, and oxygen concentrators through subsidiary operations
Employee Stock Option Plan and Corporate Actions
During Q3FY26, Avantel allotted 4,97,410 equity shares of face value ₹2 each to eligible employees under the Avantel Employee Stock Option Plan, 2023. Employee benefit expenses included ₹177.19 lakhs related to this stock option plan for the quarter and ₹502.16 lakhs for the nine-month period.
Key Financial Highlights
The company's expense structure showed mixed trends during Q3FY26. While cost of materials consumed decreased to ₹2,274.76 lakhs from ₹2,828.95 lakhs in Q3FY25, other expenses increased significantly to ₹1,396.49 lakhs from ₹924.17 lakhs. Finance costs rose to ₹177.26 lakhs compared to ₹101.91 lakhs in the corresponding previous quarter.
Depreciation and amortization expenses increased substantially to ₹483.16 lakhs from ₹295.19 lakhs, reflecting the company's continued investment in infrastructure and technology capabilities. The results were reviewed by statutory auditors Grandhy & Co., Chartered Accountants, and approved by the Audit Committee before being taken on record by the Board of Directors.
Historical Stock Returns for Avantel
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.95% | -10.46% | -14.41% | -7.79% | +3.38% | -29.86% |
15
